0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Carcinoma of the Thyroid

Jerome J. DeCosse, MD; William H. Beierwaltes, MD; John R. Brooks, MD; Colin G. Thomas Jr., MD; Lewis B. Woolner, MD
Arch Surg. 1975;110(7):783-789. doi:10.1001/archsurg.1975.01360130015003.
Text Size: A A A
Published online

Dr. Decosse: During the past ten to 20 years, there has been a notable evolution in the diagnosis and management of the more differentiated forms of carcinoma of the thyroid. No single contribution stands out as having redirected the course of therapy of patients with these tumors, but, from many different studies, gradual trends have emerged.

It now seems accepted by all that patients with papillary and follicular carcinoma of the thyroid may indeed die of cancer if they are observed long enough. Therefore, prompt and aggressive management is worthwhile. Patients may ultimately die of residual or recurrent papillary carcinoma, and, in some instances, these more favorable tumors will undergo metaplasia to lethal spindle cell and anaplastic carcinoma.

Despite unanimity about the risks of these more differentiated forms of thyroid cancer, there is considerable lack of uniformity regarding diagnosis and management. It is the purpose of this panel to establish

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();